Hypereosinophilic syndrome and Churg-Strauss syndrome: Is it clinically relevant to differentiate these syndromes?;Hypereosinophiles syndrom und Churg-Strauss-syndrom: Ist die differenzierung der syndrome klinisch relevant?

Internist

Volumn 49, Issue 3, 2008, Pages 286-296

  Hellmich, B ^a   Holl Ulrich, K ^b   Merz, H ^b   Gross, W L ^b  

^a Medizinische Klinik   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Churg Strauss syndrome; Hypereosinophilic syndrome; Imatinib; Mepolizumab

Indexed keywords

CYTOKINE; IMATINIB; INTERLEUKIN 5; MEPOLIZUMAB;

CHURG STRAUSS SYNDROME; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; NERVE CELL; PATHOGENESIS; REVIEW; T LYMPHOCYTE;

CHURG-STRAUSS SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOSUPPRESSIVE AGENTS;

EID: 40549092982     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-2009-4     Document Type: Review

References (52)